Comparison of the effect of inhaled nitric oxide and intravenous nitroglycerine on hypoxia-induced pulmonary hypertension in pigs

European Journal of Anaesthesiology

Volumn 13, Issue 5, 1996, Pages 521-529

  Troncy, E ^a   Jacob, E ^a   Peres Da Silva, E ^a   Ducruet, T ^a   Collet, J P ^a   Salazkin, I ^a   Charbonneau, M ^a   Blaise, G ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Cardiac effect; Nitric oxide; Nitroglycerine; Pig; Pulmonary hypertension; Systemic arterial pressure

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CENTRAL VENOUS PRESSURE; HEART LEFT ATRIUM PRESSURE; HEMODYNAMICS; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; NONHUMAN; PULMONARY HYPERTENSION;

EID: 0029791805     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199609000-00018     Document Type: Article

References (57)

1. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik JJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88 (part 1):2128-2138.
2. Bishop JM. Hypoxia and pulmonary hypertension in chronic bronchitis. Prog Respir Res 1975; 9: 10-16.
3. Kobayashi Y, Amenta F. Neurotransmettor receptors in the pulmonary circulation with particular emphasis on pulmonary endothelium. J Auton Pharmacol 1994; 14: 137-164.
4. Vlahakes GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: Hemodynamic and biochemical correlations. Circulation 1981; 63: 87-95.
5. Pearl RG. Inhaled Nitric Oxide - Epitomes-Anesthesiology. WJM 1995; 162: 52-53.
6. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
7. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric Oxide: A physiologic messenger. Ann Intern Med 1994; 120: 227-237.
8. Dinb-Xuan AT, Mira JP, Dall'Ava-Santucci J. Modulation of pulmonary vascular tone by nitric oxide in health and disease. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine, New-York: Springer-Verlag, 1993: 465-473.
9. Koizumi T, Gupta R, Newman JH. Inhibition of EDRF results in marked vasoconstriction of upstream pulmonary vessels during exercise in sheep. Am Rev Respi Dis 1993; 147: A226.
10. Rimard S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993; 88: 2884-2887.
11. Fratacci MD, Frostell CG, Chen T-Y, Wain Jr JC, Robinson DR, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin - protamine vasoconstriction in sheep. Anesthesiology 1991; 75: 990-999.
12. Pison U, López FA, Heidelmeyer CF, Rossaint R, Falke KJ. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 1993; 74: 1287-1292.
13. Channick RN, Newhart JW, Johnson FW, Moser KM. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs - a practical nitric oxide delivery and monitoring system. Chest 1994; 105: 1842-1847.
14. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
15. Zappol WM, Falke KJ, Hurford WE, Roberts Jr JD. Inhaling nitric oxide: A selective pulmonary vasodilator and bronchodilator. Chest Suppl 1994; 105: 87S-91S.
16. Dyar O, Young JD, Xiong L, Howell S, Johns E. Dose-response relationship for inhaled nitric oxide in experimental pulmonary hypertension in sheep. Br J Anaesth 1993; 71: 702-708.
17. Weitzberg E, Rudehill A, Lundberg JM. Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol 1993; 233: 85-94.
18. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vaso dilation. Anesthesiology 1993; 78: 427-435.
19. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173-1174.
20. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl J Med 1993; 328: 399-405.
21. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-819.
22. Haydar A, Malhere T, Mauriat P, et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992; 340: 1545.
23. Rich GF, Murphy Jr GD, Roos CM, Johns RA. Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993; 78: 1028-1035.
24. Holden EW, McCall E. Hypoxia-induced contractions of porcine pulmonary artery strips depends on intact endothelium. Exp Lung Res 1984; 7: 101-112.
25. Zellers TM, Shimokawa H, Yunginger J, Vanhoutte PM. Heterogeneity of endothelium-dependant and endothelium-independent responses to aggregating platelets in porcine pulmonary arteries. Circ Res 1991; 68: 1437-1445.
26. Hebb C. Motor innervation of the pulmonary blood vessels of mammals. In: Fishman AP, Hecht HH, eds. The Pulmonary Circulation and Interstitial Space. Chicago: University of Chicago Press, 1969: 195-217.
27. Grover RF, Wagner WW, McMurtry IF, Reeves JT. Pulmonary circulation. In: Betesda MD, ed. Handbook of Physiology the Cardiovascular System Peripheral Circulation and Organ Blood Flow. New-York: Am Physio Soc, 1983; III: 103-136.
28. Muir WW, Hubbell JAE, Skarda R. Anesthetic Procedures and Techniques in Pigs. In: Muir WW, Hubbell JAE, eds. Handbook of Veterinary Anesthesia, St Louis: The CV. Mosby Company, 1989: 228-233.
29. Dubé L, Francaeur M, Troncy E, Carrier R, Blaise G. Comparison of two administration techniques of inhaled nitric oxide on nitrogen dioxide production. Can J Anaesth 1995; 42: 922-927.
30. Searie NR. Endothelial vasomotor regulation in health and disease. Can J Anaesth 1992; 39: 838-857.
31. Moncada S, Palmer RMJ, Higgs EDA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
32. Myers PR, Minor Jr RL, Guerra Jr R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990; 345: 161-163.
33. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
34. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1-21.
35. Welch G, Loscalzo J. Nitric oxide and the cardiovascular system. J Card Surg 1994; 9: 361-371.
36. Harrison DG, Bates JN. The nitrovasodilators. New ideas about old drugs. Circulation 1993; 87: 1461-1467.
37. Kiechle FL, Malinski T. Nitric oxide: Biochemistry, pathophysiology, and detection. Am J Clin Pathol 1993; 100: 567-575.
38. Chung SJ, Fung HL. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Biochem Pharmacol 1993; 45: 157-163.
39. Tönz M, von Segesser LK, Schilling J et al. Treatment of Acute Pulmonary Hypertension With Inhaled Nitric Oxide. Ann Thorac Surg 1994; 58: 1031-1035.
40. Dinh-Xuan AT. Endothelial modulation of pulmonary vascular tone. Eur Respir J 1992; 5: 757-762.
41. Ogata M, Ohe M, Katayose D, Takishima T. Modulatory role of EDRF in hypoxic contraction of isolated porcine pulmonary arteries. Am J Physiol (Heart Circ Physiol 31) 1992; 262: H691-H697.
42. Radermacher P, Huet Y, Pluskwa F et al. Comparison of ketanserine and sodium nitroprusside in patients with severe ARDS. Anesthesiology 1988; 68: 152-157.
43. Stamler JS, Simon DI, Osborne JA et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89: 444-448.
44. Stamler JS, Jaraki OA, Osborne JA et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89: 7674-7677.
45. Keaney JF, Simon Jr DI, Stamler JS et al. NO forms and adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993; 91: 1582-1589.
46. Kaufmann MA, Castelli I, Pargger H, Drop LJ. Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: The role of serum albumin. J Pharmacol Exp Ther 1995; 273: 855-862.
47. Lia J, Bonaventura C, Stamler JS. S-nitrosohemoglobin: a new transport function of arterial erythrocytes involved in regulation of blood pressure. Endoth 1995; Suppl 3: s6 (#23).
48. Kuo PC, Schroeder RA. The Emerging Multifaceted Roles of Nitric Oxide. Ann Surg 1995; 221: 220-235.
49. Vedernikov YP, Mordvintcev PI, Malenkova IV, Vanin AF. Similarity between the vasorelaxing activity of dinitrosyl iron cysteine complexes and endothelium-derived relaxing factor. Eur J Pharmacol 1992; 211: 313-317.
50. Mulsch A, Mordvintcev PI, Vanin AF, Busse R. Formation and release of dinitrosyl iron complexes by endothelial cells. Biochem Biophys Res Communication 1993; 196: 1303-1313.
51. Troncy E, Vinay P, Francaeur M, Salazkin I, Blaise G. Nitric oxide by inhalation influences renal function in pigs. Endoth 1995; Suppl 3: s114 (#454).
52. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol (Heart Circ Physiol 34) 1993; 265: H176-H182.
53. Balligand JL, Ungureanu D, Kelly RA et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993; 91: 2314-2319.
54. Lohmann SM, Fischmeister R, Walter U. Signal transduction by cGMP in heart. Basic Res Cardiol 1991; 86: 503-514.
55. Schulze W, Krause EG. Cytochemical demonstration of guanylate cyclase activity in cardiac muscle. Histochemistry 1983; 77: 243-254.
56. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibitity in humans: Assesment by coronary sodium nitroprusside infusion. Circulation 1994; 89: 2070-2078.
57. Balligand JL, Kelly RA, Marsden RA, Smith TN, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 1993; 90: 347-351.